Request Demo
Last update 29 Aug 2025
Xinjiang Yinduolan Uighur Medicine Co., Ltd.
Last update 29 Aug 2025
Overview
Tags
Other Diseases
Respiratory Diseases
Infectious Diseases
Herbal medicine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20210975
评价苏孜阿甫片治疗稳定期白癜风（甜味黏液质型或涩味黏液质型）有效性和安全性的随机、双盲、安慰剂平行对照、多中心临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical trial to evaluate the efficacy and safety of Suzi Afu tablets in the treatment of stable vitiligo (sweet mucus type or astringent mucus type)
CTR20210690
评价醒脑库克亚片治疗有先兆或无先兆偏头痛（异常粘液质型）有效性和安全性的多中心、随机、双盲、安慰剂平行对照临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled parallel clinical trial to evaluate the efficacy and safety of Xingnao Kukeya tablets in the treatment of migraine with or without aura (abnormal phlegm type)
CTR20190322
复方一枝蒿颗粒治疗儿童急性上呼吸道感染(乃孜来型)的有效性和安全性的随机双盲安慰剂平行对照多中心临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical trial on the efficacy and safety of Compound Artemisia argyi granules in the treatment of acute upper respiratory tract infection (Naizilai type) in children
100 Clinical Results associated with Xinjiang Yinduolan Uighur Medicine Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Xinjiang Yinduolan Uighur Medicine Co., Ltd.
Login to view more data
100 Translational Medicine associated with Xinjiang Yinduolan Uighur Medicine Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 14 Sep 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3
1
2
Approved
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free